查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1449250

埃索美拉唑市场、占有率、市场规模、趋势、行业分析报告：按产品、按应用、按分销管道、按地区、按细分市场、预测，2024-2032 年

Esomeprazole Market Share, Size, Trends, Industry Analysis Report, By Product (Capsules, Tablets, Injections, Others); By Application; By Distribution Channel; By Region; Segment Forecast, 2024 - 2032
出版日期: | 出版商: Polaris Market Research | 英文 116 Pages | 商品交期: 最快1-2个工作天内

价格

根据Polaris Market Research的最新研究，预计到2032年，全球埃索美拉唑市场规模将达到287,207万美元。 该研究报告提供了对当前市场动态的详细洞察，并对未来市场成长进行了分析。

由于胃溃疡、胃食道逆流、佐林格-埃里森症候群等在全球的流行，埃索美拉唑在全球医疗保健领域变得越来越重要。 埃索美拉唑在降低胃酸方面的高效功效正在推动未来几年埃索美拉唑市场的扩张。

由于埃索美拉唑在治疗过程中的广泛应用，人们胃肠道疾病的增加表明了对埃索美拉唑的巨大需求。 2023 年的一项研究发现，感染了 COVID-19 的人当年患胃食道逆流的风险更高 (39%)，与未感染 COVID-19 病毒的人一致。感染仍在继续。 这项研究显示了研究期间市场的新增长机会。

市场参与者进入埃索美拉唑生产市场的出现可能会在未来几年增加埃索美拉唑的市场规模。 例如，2023 年，Granules India Limited 的埃索美拉唑镁缓释胶囊（20 毫克和 40 毫克剂量）获得美国食品和药物管理局 (US FDA) 的简略新药申请 (ANDA) 批准。 这些努力预计将加强该药物的市场供应。

製药公司正在加强研发力度，为许多尚未解决的健康问题（包括胃溃疡和十二指肠溃疡）创新有效的药物。 例如，2023年4月，Akmus Pharmaceuticals宣布推出一款新的组合试剂盒，用于治疗幽门螺旋桿菌感染和十二指肠溃疡。 这些新兴市场的发展可能会在全球创造新的埃索美拉唑市场机会。

网路存取的增加减少了世界上资讯不对称，并促进了医学知识的提高。 在预测期内，人口中胃部相关问题的增加可能会透过非处方药推动市场对埃索美拉唑药物的巨大需求。

越来越多的公司正在进入药品生产领域，尤其是埃索美拉唑，推动了全球市场的扩张。 例如，2023年10月，Marksans获得生产埃索美拉唑镁胶囊的批准。

埃索美拉唑市场报告亮点

胶囊预计在未来几年内成长最快，因为它们比片剂效果更好

由于胃酸逆流病例增加，胃食道逆流症市场占最大市场占有率

由于病患访问量的增加，预计医院和药局部门将占收入的更大占有率。

由于老年人口的存在，预计亚太地区将在预测期内实现最快的成长。

目录

简介

  • 报告说明
    • 研究目的
    • 市场范围
    • 假设
  • 利害关係人

第 2 章执行摘要

第3章研究方法

第4章全球埃索美拉唑市场洞察

  • 埃索美拉唑市场－通路概况
  • 埃索美拉唑市场动态
    • 推动者和机会
      • 胃肠炎病例增加推动市场发展
      • 饮食习惯的变化和肥胖的增加正在推动市场发展
    • 抑制因素和挑战
      • 与埃索美拉唑相关的副作用可能会阻碍市场成长
  • PESTEL 分析
  • 埃索美拉唑市场通路趋势
  • 价值链分析
  • COVID-19 感染的影响分析

第5章全球埃索美拉唑市场，依应用划分

  • 主要发现
  • 简介
  • 胃食道逆流病
  • 糜烂性食道炎
  • 消化性溃疡
  • 十二指肠溃疡
  • 佐林格-埃里森症候群
  • 其他

第 6 章全球埃索美拉唑市场，依产品

  • 主要发现
  • 简介
  • 胶囊
  • 平板电脑
  • 注射
  • 其他

第 7 章全球埃索美拉唑市场，依通路划分

  • 主要发现
  • 简介
  • 医院和药房
  • 网路药局
  • 非处方药

第 8 章全球埃索美拉唑市场（按地区）

  • 主要发现
  • 简介
    • 2019-2032 年埃索美拉唑市场评估（按地区）
  • 埃索美拉唑市场 - 北美
    • 北美：埃索美拉唑市场，按应用划分，2019-2032 年
    • 北美：埃索美拉唑市场，依通路划分，2019-2032 年
    • 北美：埃索美拉唑市场（按产品），2019-2032 年
    • 埃索美拉唑市场—美国
    • 埃索美拉唑市场 - 加拿大
  • 埃索美拉唑市场 - 欧洲
    • 欧洲：埃索美拉唑市场，按应用划分，2019-2032 年
    • 欧洲：埃索美拉唑市场，依通路划分，2019-2032 年
    • 欧洲：埃索美拉唑市场（按产品），2019-2032 年
    • 埃索美拉唑市场 - 英国
    • 埃索美拉唑市场 - 法国
    • 埃索美拉唑市场 - 德国
    • 埃索美拉唑市场 - 义大利
    • 埃索美拉唑市场 - 西班牙
    • 埃索美拉唑市场 - 荷兰
    • 埃索美拉唑市场 - 俄罗斯
  • 埃索美拉唑市场 - 亚太地区
    • 亚太地区：埃索美拉唑市场，依应用划分，2019-2032 年
    • 亚太地区：埃索美拉唑市场，依分销管道划分，2019-2032 年
    • 亚太地区：埃索美拉唑市场，依产品，2019-2032 年
    • 埃索美拉唑市场 - 中国
    • 埃索美拉唑市场 - 印度
    • 埃索美拉唑市场 - 马来西亚
    • 埃索美拉唑市场 - 日本
    • 埃索美拉唑市场-印度尼西亚
    • 埃索美拉唑市场-韩国
  • 埃索美拉唑市场－中东和非洲
    • 中东和非洲：埃索美拉唑市场，按应用划分，2019-2032 年
    • 中东和非洲：埃索美拉唑市场，按分销管道划分，2019-2032 年
    • 中东和非洲：埃索美拉唑市场（按产品），2019-2032 年
    • 埃索美拉唑市场 - 沙乌地阿拉伯
    • 埃索美拉唑市场 - 阿拉伯联合大公国
    • 埃索美拉唑市场 - 以色列
    • 埃索美拉唑市场 - 南非
  • 埃索美拉唑市场 - 拉丁美洲
    • 拉丁美洲：埃索美拉唑市场，按应用划分，2019-2032 年
    • 拉丁美洲：埃索美拉唑市场，依通路划分，2019-2032 年
    • 拉丁美洲：埃索美拉唑市场，副产品，2019-2032 年
    • 埃索美拉唑市场 - 墨西哥
    • 埃索美拉唑市场 - 巴西
    • 埃索美拉唑市场 - 阿根廷

第9章竞争态势

  • 扩张与收购分析
    • 放大
    • 收购
  • 伙伴关係/协作/协议/揭露

第10章公司简介

  • Actavis（US）
  • AstraZeneca AB（UK）
  • Blaskov（Columbia）
  • CQ Lummy（China）
  • KernPharm（Spain）
  • Mepha（India）
  • Mylan（US）
  • Sandoz（Switzerland）
  • Sanofi（France）
  • Saval Pharmaceutical（Chile）
  • Stada Arzneimittel AG（Germany）
  • Teva Pharmaceuticals（Israel）
Product Code: PM4436

The global esomeprazole market size is expected to reach USD 2,872.07 million by 2032, according to a new study by Polaris Market Research. The report "Esomeprazole Market Share, Size, Trends, Industry Analysis Report, By Product (Capsules, Tablets, Injections, Others); By Application; By Distribution Channel; By Region; Segment Forecast, 2024 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Esomeprazole is gaining importance in the global healthcare space attributable to the prevalence of gastric ulcers, gastroesophageal reflux disease, Zollinger-Ellison syndrome, and more in the world. The higher effectiveness of esomeprazole in lowering acid in the stomach among humans is a contributing factor fueling the expansion of the esomeprazole market in the coming years.

The increasing gastrointestinal problems in people are showcasing the significant demand for esomeprazole, as it is widely utilized in the treatment process. According to the 2023 study, people infected with COVID-19 have a higher risk (39%) of developing gastroesophageal reflux disease in the year, followed by the infection in line with the people who are not infected by the COVID-19 virus. This study demonstrates new growth opportunities for the market during the study period.

The emergence of market players entering the production of esomeprazole in the marketplace is likely to enhance the esomeprazole market size in the coming years. For instance, in 2023, Granules India Limited received the approval of an abbreviated new drug application (ANDA) for Esomeprazole Magnesium delayed-release capsules for USP, 20 mg, and 40mg strengths from the US Food and Drug Administration (US FDA). These initiatives are expected to enhance the supply of this drug on the market.

Pharmaceutical companies are boosting research and development activities to innovate effective medication for the numerous unresolved health issues, including gastric and duodenal ulcers. For instance, in April 2023, Akums Drugs and Pharmaceuticals introduced the new Combikit for the treatment of H. pylori infection and duodenal ulcer. These developments are likely to create new esomeprazole market opportunities around the world.

The increased accessibility of the internet lowered the chance of asymmetry of information in the world, driving enhanced knowledge of medicines. The rising stomach-related issues in the population are likely to facilitate significant demand for the esomeprazole drug through the over-the-counter option in the marketplace during the forecast period.

More companies are entering into the production of pharmaceutical drugs, specifically esomeprazole, driving the expansion of the global market. For instance, in October 2023, Marksans received approval to produce esomeprazole magnesium capsules.

Esomeprazole Market Report Highlights

Capsules segment is anticipated to witness the highest growth in the coming years due to its superior action over tablets.

Gastroesophageal reflux disease segment accounted for the largest market share owing to the rising incidence of acid reflux cases.

Hospitals & Clinical Pharmacies segment is projected to experience a larger revenue share attributable to the increased patient access.

APAC is projected to register the fastest growth during the forecast period attributable to the presence of the elderly population.

The global players include Actavis, AstraZeneca AB, Blaskov, CQ Lummy, KernPharm, Mepha, Mylan, Sandoz, Sanofi, Saval Pharmaceutical, Stada, & Teva.

Polaris Market Research has segmented the esomeprazole market report based on product, application, distribution channel and region:

Esomeprazole, Product Outlook (Revenue - USD Billion, 2019 - 2032)

  • Capsules
  • Tablets
  • Injections
  • Others

Esomeprazole, Application Outlook (Revenue - USD Billion, 2019 - 2032)

  • Gastroesophageal reflux disease
  • Erosive Esophagitis
  • Peptic Ulcers
  • Duodenal Ulcers
  • Zollinger-Ellison Syndrome
  • Others

Esomeprazole, Distribution Channel Outlook (Revenue - USD Billion, 2019 - 2032)

  • Hospitals & Clinical Pharmacies
  • Online Pharmacies
  • OTC

Esomeprazole, Regional Outlook (Revenue - USD Billion, 2019 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa

Table of Contents

Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Esomeprazole Market Insights

  • 4.1. Esomeprazole Market - Distribution Channel Snapshot
  • 4.2. Esomeprazole Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Rising gastroenteritis cases drives the market
      • 4.2.1.2. The changing eating patterns and rising obesity drives the market
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. The side-effects associated with esomeprazole are likely to hinder market growth
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Esomeprazole Market Distribution Channel Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Esomeprazole Market, by Application

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Esomeprazole Market, by Application, 2019-2032 (USD Million)
  • 5.3. Gastroesophageal reflux disease
    • 5.3.1. Global Esomeprazole Market, by Gastroesophageal reflux disease, by Region, 2019-2032 (USD Million)
  • 5.4. Erosive Esophagitis
    • 5.4.1. Global Esomeprazole Market, by Erosive Esophagitis, by Region, 2019-2032 (USD Million)
  • 5.5. Peptic Ulcers
    • 5.5.1. Global Esomeprazole Market, by Peptic Ulcers, by Region, 2019-2032 (USD Million)
  • 5.6. Duodenal Ulcers
    • 5.6.1. Global Esomeprazole Market, by Duodenal Ulcers, by Region, 2019-2032 (USD Million)
  • 5.7. Zollinger-Ellison Syndrome
    • 5.7.1. Global Esomeprazole Market, by Zollinger-Ellison Syndrome, by Region, 2019-2032 (USD Million)
  • 5.8. Others
    • 5.8.1. Global Esomeprazole Market, by Others, by Region, 2019-2032 (USD Million)

6. Global Esomeprazole Market, by Product

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Esomeprazole Market, by Product, 2019-2032 (USD Million)
  • 6.3. Capsules
    • 6.3.1. Global Esomeprazole Market, by Capsules, by Region, 2019-2032 (USD Million)
  • 6.4. Tablets
    • 6.4.1. Global Esomeprazole Market, by Tablets, by Region, 2019-2032 (USD Million)
  • 6.5. Injections
    • 6.5.1. Global Esomeprazole Market, by Injections, by Region, 2019-2032 (USD Million)
  • 6.6. Others
    • 6.6.1. Global Esomeprazole Market, by Others, by Region, 2019-2032 (USD Million)

7. Global Esomeprazole Market, by Distribution Channel

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Esomeprazole Market, by Distribution Channel, 2019-2032 (USD Million)
  • 7.3. Hospitals & Clinical Pharmacies
    • 7.3.1. Global Esomeprazole Market, by Hospitals & Clinical Pharmacies, By Region, 2019-2032 (USD Million)
  • 7.4. Online Pharmacies
    • 7.4.1. Global Esomeprazole Market, by Online Pharmacies, By Region, 2019-2032 (USD Million)
  • 7.5. OTC
    • 7.5.1. Global Esomeprazole Market, by OTC, By Region, 2019-2032 (USD Million)

8. Global Esomeprazole Market, by Geography

  • 8.1. Key findings
  • 8.2. Introduction
    • 8.2.1. Esomeprazole Market Assessment, By Geography, 2019-2032 (USD Million)
  • 8.3. Esomeprazole Market - North America
    • 8.3.1. North America: Esomeprazole Market, by Application, 2019-2032 (USD Million)
    • 8.3.2. North America: Esomeprazole Market, by Distribution Channel, 2019-2032 (USD Million)
    • 8.3.3. North America: Esomeprazole Market, by Product, 2019-2032 (USD Million)
    • 8.3.4. Esomeprazole Market - U.S.
      • 8.3.4.1. U.S.: Esomeprazole Market, by Application, 2019-2032 (USD Million)
      • 8.3.4.2. U.S.: Esomeprazole Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.3.4.3. U.S.: Esomeprazole Market, by Product, 2019-2032 (USD Million)
    • 8.3.5. Esomeprazole Market - Canada
      • 8.3.5.1. Canada: Esomeprazole Market, by Application, 2019-2032 (USD Million)
      • 8.3.5.2. Canada.: Esomeprazole Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.3.5.3. Canada: Esomeprazole Market, by Product, 2019-2032 (USD Million)
  • 8.4. Esomeprazole Market - Europe
    • 8.4.1. Europe: Esomeprazole Market, by Application, 2019-2032 (USD Million)
    • 8.4.2. Europe.: Esomeprazole Market, by Distribution Channel, 2019-2032 (USD Million)
    • 8.4.3. Europe: Esomeprazole Market, by Product, 2019-2032 (USD Million)
    • 8.4.4. Esomeprazole Market - UK
      • 8.4.4.1. UK: Esomeprazole Market, by Application, 2019-2032 (USD Million)
      • 8.4.4.2. UK.: Esomeprazole Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.4.4.3. UK: Esomeprazole Market, by Product, 2019-2032 (USD Million)
    • 8.4.5. Esomeprazole Market - France
      • 8.4.5.1. France: Esomeprazole Market, by Application, 2019-2032 (USD Million)
      • 8.4.5.2. France.: Esomeprazole Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.4.5.3. France: Esomeprazole Market, by Product, 2019-2032 (USD Million)
    • 8.4.6. Esomeprazole Market - Germany
      • 8.4.6.1. Germany: Esomeprazole Market, by Application, 2019-2032 (USD Million)
      • 8.4.6.2. Germany.: Esomeprazole Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.4.6.3. Germany: Esomeprazole Market, by Product, 2019-2032 (USD Million)
    • 8.4.7. Esomeprazole Market - Italy
      • 8.4.7.1. Italy: Esomeprazole Market, by Application, 2019-2032 (USD Million)
      • 8.4.7.2. Italy.: Esomeprazole Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.4.7.3. Italy: Esomeprazole Market, by Product, 2019-2032 (USD Million)
    • 8.4.8. Esomeprazole Market - Spain
      • 8.4.8.1. Spain: Esomeprazole Market, by Application, 2019-2032 (USD Million)
      • 8.4.8.2. Spain.: Esomeprazole Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.4.8.3. Spain: Esomeprazole Market, by Product, 2019-2032 (USD Million)
    • 8.4.9. Esomeprazole Market - Netherlands
      • 8.4.9.1. Netherlands: Esomeprazole Market, by Application, 2019-2032 (USD Million)
      • 8.4.9.2. Netherlands.: Esomeprazole Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.4.9.3. Netherlands: Esomeprazole Market, by Product, 2019-2032 (USD Million)
    • 8.4.10. Esomeprazole Market - Russia
      • 8.4.10.1. Russia: Esomeprazole Market, by Application, 2019-2032 (USD Million)
      • 8.4.10.2. Russia.: Esomeprazole Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.4.10.3. Russia: Esomeprazole Market, by Product, 2019-2032 (USD Million)
  • 8.5. Esomeprazole Market - Asia Pacific
    • 8.5.1. Asia Pacific: Esomeprazole Market, by Application, 2019-2032 (USD Million)
    • 8.5.2. Asia Pacific.: Esomeprazole Market, by Distribution Channel, 2019-2032 (USD Million)
    • 8.5.3. Asia Pacific: Esomeprazole Market, by Product, 2019-2032 (USD Million)
    • 8.5.4. Esomeprazole Market - China
      • 8.5.4.1. China: Esomeprazole Market, by Application, 2019-2032 (USD Million)
      • 8.5.4.2. China.: Esomeprazole Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.5.4.3. China: Esomeprazole Market, by Product, 2019-2032 (USD Million)
    • 8.5.5. Esomeprazole Market - India
      • 8.5.5.1. India: Esomeprazole Market, by Application, 2019-2032 (USD Million)
      • 8.5.5.2. India.: Esomeprazole Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.5.5.3. India: Esomeprazole Market, by Product, 2019-2032 (USD Million)
    • 8.5.6. Esomeprazole Market - Malaysia
      • 8.5.6.1. Malaysia: Esomeprazole Market, by Application, 2019-2032 (USD Million)
      • 8.5.6.2. Malaysia.: Esomeprazole Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.5.6.3. Malaysia: Esomeprazole Market, by Product, 2019-2032 (USD Million)
    • 8.5.7. Esomeprazole Market - Japan
      • 8.5.7.1. Japan: Esomeprazole Market, by Application, 2019-2032 (USD Million)
      • 8.5.7.2. Japan.: Esomeprazole Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.5.7.3. Japan: Esomeprazole Market, by Product, 2019-2032 (USD Million)
    • 8.5.8. Esomeprazole Market - Indonesia
      • 8.5.8.1. Indonesia: Esomeprazole Market, by Application, 2019-2032 (USD Million)
      • 8.5.8.2. Indonesia.: Esomeprazole Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.5.8.3. Indonesia: Esomeprazole Market, by Product, 2019-2032 (USD Million)
    • 8.5.9. Esomeprazole Market - South Korea
      • 8.5.9.1. South Korea: Esomeprazole Market, by Application, 2019-2032 (USD Million)
      • 8.5.9.2. South Korea.: Esomeprazole Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.5.9.3. South Korea: Esomeprazole Market, by Product, 2019-2032 (USD Million)
  • 8.6. Esomeprazole Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Esomeprazole Market, by Application, 2019-2032 (USD Million)
    • 8.6.2. Middle East & Africa.: Esomeprazole Market, by Distribution Channel, 2019-2032 (USD Million)
    • 8.6.3. Middle East & Africa: Esomeprazole Market, by Product, 2019-2032 (USD Million)
    • 8.6.4. Esomeprazole Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Esomeprazole Market, by Application, 2019-2032 (USD Million)
      • 8.6.4.2. Saudi Arabia.: Esomeprazole Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.6.4.3. Saudi Arabia: Esomeprazole Market, by Product, 2019-2032 (USD Million)
    • 8.6.5. Esomeprazole Market - UAE
      • 8.6.5.1. UAE: Esomeprazole Market, by Application, 2019-2032 (USD Million)
      • 8.6.5.2. UAE.: Esomeprazole Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.6.5.3. UAE: Esomeprazole Market, by Product, 2019-2032 (USD Million)
    • 8.6.6. Esomeprazole Market - Israel
      • 8.6.6.1. Israel: Esomeprazole Market, by Application, 2019-2032 (USD Million)
      • 8.6.6.2. Israel.: Esomeprazole Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.6.6.3. Israel: Esomeprazole Market, by Product, 2019-2032 (USD Million)
    • 8.6.7. Esomeprazole Market - South Africa
      • 8.6.7.1. South Africa: Esomeprazole Market, by Application, 2019-2032 (USD Million)
      • 8.6.7.2. South Africa.: Esomeprazole Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.6.7.3. South Africa: Esomeprazole Market, by Product, 2019-2032 (USD Million)
  • 8.7. Esomeprazole Market - Latin America
    • 8.7.1. Latin America: Esomeprazole Market, by Application, 2019-2032 (USD Million)
    • 8.7.2. Latin America.: Esomeprazole Market, by Distribution Channel, 2019-2032 (USD Million)
    • 8.7.3. Latin America: Esomeprazole Market, by Product, 2019-2032 (USD Million)
    • 8.7.4. Esomeprazole Market - Mexico
      • 8.7.4.1. Mexico: Esomeprazole Market, by Application, 2019-2032 (USD Million)
      • 8.7.4.2. Mexico.: Esomeprazole Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.7.4.3. Mexico: Esomeprazole Market, by Product, 2019-2032 (USD Million)
    • 8.7.5. Esomeprazole Market - Brazil
      • 8.7.5.1. Brazil: Esomeprazole Market, by Application, 2019-2032 (USD Million)
      • 8.7.5.2. Brazil.: Esomeprazole Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.7.5.3. Brazil: Esomeprazole Market, by Product, 2019-2032 (USD Million)
    • 8.7.6. Esomeprazole Market - Argentina
      • 8.7.6.1. Argentina: Esomeprazole Market, by Application, 2019-2032 (USD Million)
      • 8.7.6.2. Argentina.: Esomeprazole Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.7.6.3. Argentina: Esomeprazole Market, by Product, 2019-2032 (USD Million)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. Actavis (US)
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. AstraZeneca AB (UK)
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. Blaskov (Columbia)
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. CQ Lummy (China)
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. KernPharm (Spain)
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. Mepha (India)
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. Mylan (US)
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. Sandoz (Switzerland)
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. Sanofi (France)
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. Saval Pharmaceutical (Chile)
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development
  • 10.11. Stada Arzneimittel AG (Germany)
    • 10.11.1. Company Overview
    • 10.11.2. Financial Performance
    • 10.11.3. Product Benchmarking
    • 10.11.4. Recent Development
  • 10.12. Teva Pharmaceuticals (Israel)
    • 10.12.1. Company Overview
    • 10.12.2. Financial Performance
    • 10.12.3. Product Benchmarking
    • 10.12.4. Recent Development

List of Tables

  • Table 1 Global Esomeprazole Market, by Application, 2019-2032 (USD Million)
  • Table 2 Global Esomeprazole Market, by Product, 2019-2032 (USD Million)
  • Table 3 Global Esomeprazole Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 4 Esomeprazole Market Assessment, By Geography, 2019-2032 (USD Million)
  • Table 5 North America: Esomeprazole Market, by Application, 2019-2032 (USD Million)
  • Table 6 North America: Esomeprazole Market, by Product, 2019-2032 (USD Million)
  • Table 7 North America: Esomeprazole Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 8 U.S.: Esomeprazole Market, by Application, 2019-2032 (USD Million)
  • Table 9 U.S.: Esomeprazole Market, by Product, 2019-2032 (USD Million)
  • Table 10 U.S.: Esomeprazole Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 11 Canada: Esomeprazole Market, by Application, 2019-2032 (USD Million)
  • Table 12 Canada: Esomeprazole Market, by Product, 2019-2032 (USD Million)
  • Table 13 Canada: Esomeprazole Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 14 Europe: Esomeprazole Market, by Application, 2019-2032 (USD Million)
  • Table 15 Europe: Esomeprazole Market, by Product, 2019-2032 (USD Million)
  • Table 16 Europe: Esomeprazole Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 17 UK: Esomeprazole Market, by Application, 2019-2032 (USD Million)
  • Table 18 UK: Esomeprazole Market, by Product, 2019-2032 (USD Million)
  • Table 19 UK: Esomeprazole Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 20 France: Esomeprazole Market, by Application, 2019-2032 (USD Million)
  • Table 21 France: Esomeprazole Market, by Product, 2019-2032 (USD Million)
  • Table 22 France: Esomeprazole Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 23 Germany: Esomeprazole Market, by Application, 2019-2032 (USD Million)
  • Table 24 Germany: Esomeprazole Market, by Product, 2019-2032 (USD Million)
  • Table 25 Germany: Esomeprazole Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 26 Italy: Esomeprazole Market, by Application, 2019-2032 (USD Million)
  • Table 27 Italy: Esomeprazole Market, by Product, 2019-2032 (USD Million)
  • Table 28 Italy: Esomeprazole Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 29 Spain: Esomeprazole Market, by Application, 2019-2032 (USD Million)
  • Table 30 Spain: Esomeprazole Market, by Product, 2019-2032 (USD Million)
  • Table 31 Spain: Esomeprazole Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 32 Netherlands: Esomeprazole Market, by Application, 2019-2032 (USD Million)
  • Table 33 Netherlands: Esomeprazole Market, by Product, 2019-2032 (USD Million)
  • Table 34 Netherlands: Esomeprazole Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 35 Russia: Esomeprazole Market, by Application, 2019-2032 (USD Million)
  • Table 36 Russia: Esomeprazole Market, by Product, 2019-2032 (USD Million)
  • Table 37 Russia: Esomeprazole Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 38 Asia Pacific: Esomeprazole Market, by Application, 2019-2032 (USD Million)
  • Table 39 Asia Pacific: Esomeprazole Market, by Product, 2019-2032 (USD Million)
  • Table 40 Asia Pacific: Esomeprazole Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 41 China: Esomeprazole Market, by Application, 2019-2032 (USD Million)
  • Table 42 China: Esomeprazole Market, by Product, 2019-2032 (USD Million)
  • Table 43 China: Esomeprazole Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 44 India: Esomeprazole Market, by Application, 2019-2032 (USD Million)
  • Table 45 India: Esomeprazole Market, by Product, 2019-2032 (USD Million)
  • Table 46 India: Esomeprazole Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 47 Malaysia: Esomeprazole Market, by Application, 2019-2032 (USD Million)
  • Table 48 Malaysia: Esomeprazole Market, by Product, 2019-2032 (USD Million)
  • Table 49 Malaysia: Esomeprazole Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 50 Japan: Esomeprazole Market, by Application, 2019-2032 (USD Million)
  • Table 51 Japan: Esomeprazole Market, by Product, 2019-2032 (USD Million)
  • Table 52 Japan: Esomeprazole Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 53 Indonesia: Esomeprazole Market, by Application, 2019-2032 (USD Million)
  • Table 54 Indonesia: Esomeprazole Market, by Product, 2019-2032 (USD Million)
  • Table 55 Indonesia: Esomeprazole Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 56 South Korea: Esomeprazole Market, by Application, 2019-2032 (USD Million)
  • Table 57 South Korea: Esomeprazole Market, by Product, 2019-2032 (USD Million)
  • Table 58 South Korea: Esomeprazole Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 59 Middle East & Africa: Esomeprazole Market, by Application, 2019-2032 (USD Million)
  • Table 60 Middle East & Africa: Esomeprazole Market, by Product, 2019-2032 (USD Million)
  • Table 61 Middle East & Africa: Esomeprazole Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 62 Saudi Arabia: Esomeprazole Market, by Application, 2019-2032 (USD Million)
  • Table 63 Saudi Arabia: Esomeprazole Market, by Product, 2019-2032 (USD Million)
  • Table 64 Saudi Arabia: Esomeprazole Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 65 UAE: Esomeprazole Market, by Application, 2019-2032 (USD Million)
  • Table 66 UAE: Esomeprazole Market, by Product, 2019-2032 (USD Million)
  • Table 67 UAE: Esomeprazole Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 68 Israel: Esomeprazole Market, by Application, 2019-2032 (USD Million)
  • Table 69 Israel: Esomeprazole Market, by Product, 2019-2032 (USD Million)
  • Table 70 Israel: Esomeprazole Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 71 South Africa: Esomeprazole Market, by Application, 2019-2032 (USD Million)
  • Table 72 South Africa: Esomeprazole Market, by Product, 2019-2032 (USD Million)
  • Table 73 South Africa: Esomeprazole Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 74 Latin America: Esomeprazole Market, by Application, 2019-2032 (USD Million)
  • Table 75 Latin America: Esomeprazole Market, by Product, 2019-2032 (USD Million)
  • Table 76 Latin America: Esomeprazole Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 77 Mexico: Esomeprazole Market, by Application, 2019-2032 (USD Million)
  • Table 78 Mexico: Esomeprazole Market, by Product, 2019-2032 (USD Million)
  • Table 79 Mexico: Esomeprazole Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 80 Brazil: Esomeprazole Market, by Application, 2019-2032 (USD Million)
  • Table 81 Brazil: Esomeprazole Market, by Product, 2019-2032 (USD Million)
  • Table 82 Brazil: Esomeprazole Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 83 Argentina: Esomeprazole Market, by Application, 2019-2032 (USD Million)
  • Table 84 Argentina: Esomeprazole Market, by Product, 2019-2032 (USD Million)
  • Table 85 Argentina: Esomeprazole Market, by Distribution Channel, 2019-2032 (USD Million)

List of Figures

  • Figure 1. Global Esomeprazole Market, 2019-2032 (USD Million)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Approach
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Product
  • Figure 7. Global Esomeprazole Market, by Product, 2022 & 2032 (USD Million)
  • Figure 8. Market by Application
  • Figure 9. Global Esomeprazole Market, by Application, 2022 & 2032 (USD Million)
  • Figure 10. Market by Distribution Channel
  • Figure 11. Global Esomeprazole Market, by Distribution Channel, 2022 & 2032 (USD Million)
  • Figure 12. Esomeprazole Market Assessment, By Geography, 2019-2032 (USD Million)
  • Figure 13. Strategic Analysis - Esomeprazole Market